MGMT and glioma: In T269 gliomas derived from another MGMT promoter hypermethylated GBMSC line which is more sensitive to chemotherapy than S24 and also more quickly proliferating in vivo18, perivascular glioblastoma cells also resisted TMZ better than parenchymal ones (Fig. 4g).